GAS5 and metabolic dysfunction-associated steatotic liver disease: One study by Han et al. [22] showed that both liver and plasma lncRNA GAS5 expression were positively correlated with the progression of liver fibrosis in 51 patients with NAFLD, and this was more apparent in plasma.